Floatz logo

Spironolactone

Acute Ischemic Stroke

Xinqiao Hospital of ChongqingSmall moleculePhase 3Active
B
56/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
52/ 100
Competitive Position
65/ 100

Competitive context

106 Active assets in the Acute Ischemic Stroke cohort.

Asset / SponsorPhaseRating
Compound Edaravone
Nanfang Hospital, Southern Medical University
Phase 4BBB
Tenecteplase
Hackensack Meridian Health
Phase 4BBB
3-N-BUTYLPHTHALIDE
Nanfang Hospital, Southern Medical University
Phase 4BBB
Tirofiban
Weifang Medical University
Phase 4BB
Human Urinary Kallidinogenase
China-Japan Union Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Spironolactone is also rated in:

AscitesDormant
BB
Indicative ·
68 / 100
View asset →
cirrhosis of liverDormant
BB
Indicative ·
66 / 100
View asset →
diabetic kidney diseaseDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →